Nuix (ASX:NXL) Shares Ask Whether Neo Growth Justifies Premium P/E

Simply Wall St.

Yesterday

Nuix walked into this earnings release with the stock at A$2.15 after a strong few months of gains, and the market already pricing in a premium P/E multiple. The immediate question for you is whether ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/news/2662730399"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2662730399\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2662730399?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959","is_english":true,"pubTime":"2026-08-25 18:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2662730399","market":"hk","top_or_hot":-1,"title":"Nuix (ASX:NXL) Shares Ask Whether Neo Growth Justifies Premium P/E","media":"Simply Wall St.","content":"<div>\n<p>Nuix walked into this earnings release with the stock at A$2.15 after a strong few months of gains, and the market already pricing in a premium P/E multiple. The immediate question for you is whether ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-shares-ask-whether-neo-growth-justifies-premium\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nuix (ASX:NXL) Shares Ask Whether Neo Growth Justifies Premium P/E</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNuix (ASX:NXL) Shares Ask Whether Neo Growth Justifies Premium P/E\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-08-25 18:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-shares-ask-whether-neo-growth-justifies-premium><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nuix walked into this earnings release with the stock at A$2.15 after a strong few months of gains, and the market already pricing in a premium P/E multiple. The immediate question for you is whether ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-shares-ask-whether-neo-growth-justifies-premium\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4082","symbol_name":"医疗保健设备","start_time":0,"source_url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-shares-ask-whether-neo-growth-justifies-premium","article_id":"2662730399","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/8041000-choice1-main-header/1585186668959"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/software/asx-nxl/nuix-shares/news/nuix-asxnxl-shares-ask-whether-neo-growth-justifies-premium","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2662730399","pubTimestamp":1787653183,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Nuix walked into this earnings release with the stock at A$2.15 after a strong few months of gains, and the market already pricing in a premium P/E multiple. The immediate question for you is whether the latest numbers justify that optimism or whether the valuation strain starts to bite.\nThe headline is profit and cash. Nuix reported full year revenue of A$263.2m and net income of A$16.4m on a trailing twelve month basis, with adjusted management EBITDA of A$59.8m. That moves the story from...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4082":"医疗保健设备","BK7016":"应用软件","NXL":"Nexalin Technology, Inc.","NXL.AU":"NUIX LTD"},"translate_title":"Nuix (ASX:NXL) 股票询问 Neo 增长是否证明溢价市盈率是合理的","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NXL.AU":1.5,"NXL":1.5},"content_text":"Nuix walked into this earnings release with the stock at A$2.15 after a strong few months of gains, and the market already pricing in a premium P/E multiple. The immediate question for you is whether the latest numbers justify that optimism or whether the valuation strain starts to bite. The headline is profit and cash. Nuix reported full year revenue of A$263.2m and net income of A$16.4m on a trailing twelve month basis, with adjusted management EBITDA of A$59.8m. That moves the story from turnaround talk to a business now producing earnings and cash that investors can properly scrutinise against the high multiple. Is Nuix a genuine bargain on a DCF view, or just an expensive growth story trading on a stretched P/E? See whether the market is overreacting or underestimating the stock with our valuation analysis for Nuix AdvertisementFY 2026 Earnings Summary  Revenue FY 2026: A$263.2m vs. A$221.5m in FY 2025 (up 18.8%) Net Income FY 2026: A$16.4m vs. a loss of A$9.2m in FY 2025 (returned to profit) Basic EPS FY 2026: A$0.049 vs. a loss of A$0.028 in FY 2025 (returned to positive EPS) Adjusted Management EBITDA FY 2026: A$59.8m vs. A$37.4m in FY 2025 (up 60.0%)  Prefer clean, visual charts instead of pages of earnings tables and raw figures about Nuix? See the full financial picture including how the valuation stacks up in our company report for Nuix. ASX:NXL Trailing 12-Month Earnings & Revenue History as at Aug 2026 Nuix Neo Milestones Start To Back The Bull Case Bulls argue Nuix can turn its AI driven Neo platform and SaaS push into more predictable, higher quality recurring revenue from large regulated customers. The FY26 print gives some concrete milestones against that claim. Neo now accounts for 30% of annual contract value, up from 12% a year earlier, with Neo ACV at A$78.5m across 135 customers. That is real traction in moving existing and new users onto the platform rather than a theoretical roadmap. The bullish story also leans on stronger recurring economics. ACV reached A$260m, within guidance, and net dollar retention of 105.2% shows existing customers on average are spending more, not less. Management’s focus on large enterprises with over A$500k ACV potential fits that thesis. The Linkurious acquisition contributing A$12m of ACV and early cross sell wins adds another proof point that Neo can support a broader, higher value platform over time. Compare that internal momentum with external expectations and see whether analysts think Nuix deserves this kind of rerating by checking the consensus price target analysis for Nuix. Nuix Bears Focus On Concentration And Cost Risks Bears argue Nuix relies too much on a narrow set of big government and regulator contracts, while needing heavy, ongoing R&D to stay relevant against larger cloud and AI vendors. The FY26 result does not clear those concerns. Reported churn of 6.6% tied largely to one APAC customer shows how a single contract can still swing regional performance and revenue visibility. ACV of A$260m sits within guidance, and organic growth excluding Linkurious of 8.6% highlights how much the contribution from acquisitions now matters to the story. On costs, management has flagged a one off A$15m R&D “accelerator” in FY27 and expects EBITDA to be similar to FY26. That effectively signals higher product spend absorbing operating leverage. For a stock sold on a cleaner recurring profile, these missed milestones on diversification and self funded R&D comfort keep the bearish thesis alive. After a year shaped by one off items and heavier R&D, you may want to know if this is just normal investment or a sign of structural pressure. Review our independent risk analysis for Nuix which shows 1 important warning sign Stay Ahead With Simply Wall St If Nuix’s shift to profit and recurring Neo revenue has your attention, register for free with Simply Wall St and add it to a Watchlist to keep an eye on share price versus fair value and wait for an entry point that fits your plan. Once you are invested, use the Portfolio Command Center to cut through noise and focus on the key fundamental developments that matter to your holdings. For a longer term view, turn to the Community to see how other investors are thinking about the same risks and catalysts. This way you spot potential inflection points earlier, understand the trade off between risk and reward more clearly, and stay one step ahead of the market. Seeking Alternatives Beyond Nuix? Fresh ideas move quickly. Some stocks are building breakout momentum while others stay under the radar for now. Before the crowd catches on and pricing shifts, consider reviewing potential opportunities.  Target resilient cash flows and lower volatility by reviewing our curated list of 10 resilient stocks with low risk scores that could help balance the punchier parts of your portfolio. Explore potential AI exposure by scanning 76 profitable AI stocks that aren't just burning cash where companies already generate real earnings rather than relying purely on future promises. Consider long term infrastructure themes by checking 38 power grid technology and infrastructure stocks that may benefit if grid upgrades and electrification spending continue to develop.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Nuix might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}